<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00115258</url>
  </required_header>
  <id_info>
    <org_study_id>86483</org_study_id>
    <secondary_id>03-11-192</secondary_id>
    <nct_id>NCT00115258</nct_id>
  </id_info>
  <brief_title>Nutrition Support in Pediatric Stem Cell Transplantation</brief_title>
  <official_title>Nutrition Support in Pediatric Stem Cell Transplantation - A Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Children’s Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine which method of providing parenteral nutrition
      (complete intravenous nutrition) will provide the best nutritional and clinical results to
      children undergoing hematopoietic stem cell transplantation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2004</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in % body fat at baseline, day +30, and day +100.</measure>
    <time_frame>day 30</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body composition measured by DXA, BIA, and 4-site skinfolds.</measure>
    <time_frame>baseline, day 30, and day 100</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in body composition from baseline to day +100.</measure>
    <time_frame>day 100</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin resistance, defined by HOMA, at each time point.</measure>
    <time_frame>baseline, day 30, and day 100</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measured resting energy expenditure (REE) at each time point.</measure>
    <time_frame>baseline, day 30, and day 100</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in percent predicted REE between the two groups.</measure>
    <time_frame>baseline, day 30, and day 100</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between body composition and measured REE.</measure>
    <time_frame>baseline, day 30, and day 100</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resumption of oral intake.</measure>
    <time_frame>day 30</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Hematopoietic Stem Cell Transplantation</condition>
  <arm_group>
    <arm_group_label>parenteral nutrition titrated to measured REE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>parenteral nutrition titrated to measured REE</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard of care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>parenteral nutrition titrated to measured REE</intervention_name>
    <arm_group_label>parenteral nutrition titrated to measured REE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  First myeloablative allogeneic SCT using either TBI (1400 cGy) or busulfan in addition
             to other chemotherapeutic agents

          -  GVHD prophylaxis with a calcineurin-inhibitor and methotrexate +/- corticosteroids

          -  Matched, related or 6/6 HLA-matched unrelated SCT donor

          -  Age 6 years and older

        Exclusion Criteria:

          -  Age less than 6 years, or otherwise unable to comply with study procedures

          -  Underweight (body mass index (BMI) z-score &lt;2 for age and sex) at baseline

          -  Overweight (BMI z-score &gt;2 for age and sex) at baseline

          -  Unable or unwilling to return for day + 100 studies

          -  Previous stem cell transplant

          -  Unmatched SCT donor

          -  Current treatment for hypo- or hyperthyroidism

          -  Current insulin dependent diabetes

          -  Current use of parenteral nutrition

          -  Allergy to egg or soy products

          -  Other contraindication to parenteral nutrition at baseline
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher P. Duggan, M.D., M.P.H.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children’s Hospital</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <reference>
    <citation>Duggan C, Bechard L, Donovan K, Vangel M, O'Leary A, Holmes C, Lehmann L, Guinan E. Changes in resting energy expenditure among children undergoing allogeneic stem cell transplantation. Am J Clin Nutr. 2003 Jul;78(1):104-9.</citation>
    <PMID>12816778</PMID>
  </reference>
  <reference>
    <citation>Bechard LJ, Feldman HA, Gordon C, Gura K, Sonis A, Leung K, Venick R, Guinan EC, Duggan C. A multi-center, randomized, controlled trial of parenteral nutrition titrated to resting energy expenditure in children undergoing hematopoietic stem cell transplantation (&quot;PNTREE&quot;): rationale and design. Contemp Clin Trials. 2010 Mar;31(2):157-64. doi: 10.1016/j.cct.2009.12.002. Epub 2010 Jan 3.</citation>
    <PMID>20004739</PMID>
  </reference>
  <results_reference>
    <citation>Sharma TS, Bechard LJ, Feldman HA, Venick R, Gura K, Gordon CM, Sonis A, Guinan EC, Duggan C. Effect of titrated parenteral nutrition on body composition after allogeneic hematopoietic stem cell transplantation in children: a double-blind, randomized, multicenter trial. Am J Clin Nutr. 2012 Feb;95(2):342-51. doi: 10.3945/ajcn.111.026005. Epub 2011 Dec 28.</citation>
    <PMID>22205317</PMID>
  </results_reference>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2005</study_first_submitted>
  <study_first_submitted_qc>June 21, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2005</study_first_posted>
  <last_update_submitted>February 12, 2013</last_update_submitted>
  <last_update_submitted_qc>February 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children’s Hospital</investigator_affiliation>
    <investigator_full_name>Christopher Duggan</investigator_full_name>
    <investigator_title>Associate professor of pediatrics</investigator_title>
  </responsible_party>
  <keyword>Nutrition, Parenteral</keyword>
  <keyword>Body Composition</keyword>
  <keyword>Energy Expenditure</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

